nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—PKN1—synovial membrane of synovial joint—osteoarthritis	0.0188	0.0649	CbGeAlD
Sunitinib—BMP2K—synovial membrane of synovial joint—osteoarthritis	0.0131	0.0451	CbGeAlD
Sunitinib—RPS6KB1—leg—osteoarthritis	0.0113	0.0388	CbGeAlD
Sunitinib—RPS6KB1—forelimb—osteoarthritis	0.0112	0.0385	CbGeAlD
Sunitinib—RPS6KB1—hindlimb—osteoarthritis	0.01	0.0347	CbGeAlD
Sunitinib—MYLK2—tendon—osteoarthritis	0.00801	0.0276	CbGeAlD
Sunitinib—KDR—hindlimb—osteoarthritis	0.00744	0.0257	CbGeAlD
Sunitinib—HUNK—tendon—osteoarthritis	0.00607	0.0209	CbGeAlD
Sunitinib—MYLK4—tendon—osteoarthritis	0.00516	0.0178	CbGeAlD
Sunitinib—MYLK3—tendon—osteoarthritis	0.005	0.0172	CbGeAlD
Sunitinib—NIM1K—tendon—osteoarthritis	0.00439	0.0151	CbGeAlD
Sunitinib—PRKAA2—tendon—osteoarthritis	0.00421	0.0145	CbGeAlD
Sunitinib—STK17B—tendon—osteoarthritis	0.00405	0.014	CbGeAlD
Sunitinib—STK17A—tendon—osteoarthritis	0.00373	0.0129	CbGeAlD
Sunitinib—CDK14—tendon—osteoarthritis	0.00368	0.0127	CbGeAlD
Sunitinib—LATS2—tendon—osteoarthritis	0.00362	0.0125	CbGeAlD
Sunitinib—CLK4—tendon—osteoarthritis	0.00344	0.0119	CbGeAlD
Sunitinib—SBK1—tendon—osteoarthritis	0.0034	0.0117	CbGeAlD
Sunitinib—DAPK1—tendon—osteoarthritis	0.00332	0.0115	CbGeAlD
Sunitinib—PHKG1—tendon—osteoarthritis	0.00332	0.0115	CbGeAlD
Sunitinib—RIOK1—tendon—osteoarthritis	0.00319	0.011	CbGeAlD
Sunitinib—RPS6KA1—tendon—osteoarthritis	0.00319	0.011	CbGeAlD
Sunitinib—TNIK—tendon—osteoarthritis	0.00313	0.0108	CbGeAlD
Sunitinib—MARK2—tendon—osteoarthritis	0.00313	0.0108	CbGeAlD
Sunitinib—SGK3—tendon—osteoarthritis	0.0031	0.0107	CbGeAlD
Sunitinib—ICK—tendon—osteoarthritis	0.00307	0.0106	CbGeAlD
Sunitinib—CHEK2—tendon—osteoarthritis	0.00296	0.0102	CbGeAlD
Sunitinib—NUAK1—tendon—osteoarthritis	0.00296	0.0102	CbGeAlD
Sunitinib—OXSR1—tendon—osteoarthritis	0.00294	0.0101	CbGeAlD
Sunitinib—SNRK—tendon—osteoarthritis	0.00294	0.0101	CbGeAlD
Sunitinib—INSR—tendon—osteoarthritis	0.00294	0.0101	CbGeAlD
Sunitinib—RPS6KA2—tendon—osteoarthritis	0.00289	0.00998	CbGeAlD
Sunitinib—STK38—tendon—osteoarthritis	0.00289	0.00998	CbGeAlD
Sunitinib—AURKC—tendon—osteoarthritis	0.00287	0.0099	CbGeAlD
Sunitinib—CSNK1G2—tendon—osteoarthritis	0.00285	0.00982	CbGeAlD
Sunitinib—PKN1—tendon—osteoarthritis	0.00285	0.00982	CbGeAlD
Sunitinib—PRPF4—tendon—osteoarthritis	0.00281	0.00968	CbGeAlD
Sunitinib—PRPF4B—tendon—osteoarthritis	0.00277	0.00954	CbGeAlD
Sunitinib—STK39—tendon—osteoarthritis	0.00273	0.00941	CbGeAlD
Sunitinib—CSNK2A1—tendon—osteoarthritis	0.00269	0.00929	CbGeAlD
Sunitinib—PHKG2—tendon—osteoarthritis	0.00256	0.00884	CbGeAlD
Sunitinib—STK24—tendon—osteoarthritis	0.00255	0.00879	CbGeAlD
Sunitinib—DAPK2—tendon—osteoarthritis	0.00252	0.00869	CbGeAlD
Sunitinib—STK16—tendon—osteoarthritis	0.00248	0.00855	CbGeAlD
Sunitinib—HIPK2—tendon—osteoarthritis	0.00247	0.0085	CbGeAlD
Sunitinib—HIPK3—tendon—osteoarthritis	0.00247	0.0085	CbGeAlD
Sunitinib—TNK1—tendon—osteoarthritis	0.00244	0.00842	CbGeAlD
Sunitinib—RIOK2—tendon—osteoarthritis	0.00244	0.00842	CbGeAlD
Sunitinib—MAP4K1—tendon—osteoarthritis	0.00242	0.00833	CbGeAlD
Sunitinib—DAPK3—tendon—osteoarthritis	0.00237	0.00817	CbGeAlD
Sunitinib—CLK2—tendon—osteoarthritis	0.00235	0.00809	CbGeAlD
Sunitinib—MAP4K2—tendon—osteoarthritis	0.00234	0.00806	CbGeAlD
Sunitinib—STK3—tendon—osteoarthritis	0.0023	0.00795	CbGeAlD
Sunitinib—MERTK—tendon—osteoarthritis	0.00217	0.00747	CbGeAlD
Sunitinib—MAP4K4—tendon—osteoarthritis	0.00213	0.00734	CbGeAlD
Sunitinib—MAP3K12—tendon—osteoarthritis	0.0021	0.00723	CbGeAlD
Sunitinib—RPS6KA3—tendon—osteoarthritis	0.00207	0.00713	CbGeAlD
Sunitinib—CSNK1A1—tendon—osteoarthritis	0.00203	0.00699	CbGeAlD
Sunitinib—CLK1—tendon—osteoarthritis	0.00201	0.00695	CbGeAlD
Sunitinib—CAMK2G—tendon—osteoarthritis	0.00198	0.00682	CbGeAlD
Sunitinib—BMP2K—tendon—osteoarthritis	0.00198	0.00682	CbGeAlD
Sunitinib—LRRK2—tendon—osteoarthritis	0.00196	0.00676	CbGeAlD
Sunitinib—PTK2B—tendon—osteoarthritis	0.00191	0.00659	CbGeAlD
Sunitinib—CSNK1E—tendon—osteoarthritis	0.00188	0.00648	CbGeAlD
Sunitinib—FGFR1—tendon—osteoarthritis	0.00188	0.00648	CbGeAlD
Sunitinib—IRAK4—tendon—osteoarthritis	0.00185	0.00638	CbGeAlD
Sunitinib—MAP2K2—tendon—osteoarthritis	0.00181	0.00624	CbGeAlD
Sunitinib—ULK3—tendon—osteoarthritis	0.00181	0.00624	CbGeAlD
Sunitinib—MAP3K7—tendon—osteoarthritis	0.00178	0.00613	CbGeAlD
Sunitinib—TBK1—tendon—osteoarthritis	0.00176	0.00606	CbGeAlD
Sunitinib—TYK2—tendon—osteoarthritis	0.00175	0.00602	CbGeAlD
Sunitinib—IRAK1—tendon—osteoarthritis	0.00172	0.00595	CbGeAlD
Sunitinib—RPS6KB1—tendon—osteoarthritis	0.00169	0.00583	CbGeAlD
Sunitinib—FGR—tendon—osteoarthritis	0.00168	0.0058	CbGeAlD
Sunitinib—RET—tendon—osteoarthritis	0.00168	0.0058	CbGeAlD
Sunitinib—AXL—tendon—osteoarthritis	0.00167	0.00578	CbGeAlD
Sunitinib—SLK—tendon—osteoarthritis	0.00161	0.00556	CbGeAlD
Sunitinib—JAK2—tendon—osteoarthritis	0.00159	0.00548	CbGeAlD
Sunitinib—FYN—tendon—osteoarthritis	0.00157	0.00541	CbGeAlD
Sunitinib—MAP3K3—tendon—osteoarthritis	0.00153	0.00528	CbGeAlD
Sunitinib—MAP4K5—tendon—osteoarthritis	0.00153	0.00528	CbGeAlD
Sunitinib—FLT1—tendon—osteoarthritis	0.00148	0.00511	CbGeAlD
Sunitinib—EPHB6—tendon—osteoarthritis	0.00146	0.00505	CbGeAlD
Sunitinib—YES1—tendon—osteoarthritis	0.00141	0.00488	CbGeAlD
Sunitinib—STK10—tendon—osteoarthritis	0.0014	0.00483	CbGeAlD
Sunitinib—TAOK3—tendon—osteoarthritis	0.0014	0.00482	CbGeAlD
Sunitinib—PDGFRA—tendon—osteoarthritis	0.00139	0.00479	CbGeAlD
Sunitinib—KDR—tendon—osteoarthritis	0.00125	0.00432	CbGeAlD
Sunitinib—MAP2K5—tendon—osteoarthritis	0.00125	0.00432	CbGeAlD
Sunitinib—CSF1R—tendon—osteoarthritis	0.00122	0.00421	CbGeAlD
Sunitinib—PDGFRB—tendon—osteoarthritis	0.00108	0.00374	CbGeAlD
Sunitinib—ABCC4—tendon—osteoarthritis	0.000862	0.00298	CbGeAlD
Sunitinib—ABCC2—tendon—osteoarthritis	0.000835	0.00288	CbGeAlD
Sunitinib—TBK1—Immune System—IL6—osteoarthritis	1.82e-05	2.57e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—CXCL8—osteoarthritis	1.82e-05	2.56e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—LEP—osteoarthritis	1.82e-05	2.56e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TGFB1—osteoarthritis	1.81e-05	2.55e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SMAD3—osteoarthritis	1.8e-05	2.53e-05	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—IL6—osteoarthritis	1.8e-05	2.53e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—BGN—osteoarthritis	1.8e-05	2.53e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—IL6—osteoarthritis	1.8e-05	2.53e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—LEP—osteoarthritis	1.79e-05	2.52e-05	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—IL6—osteoarthritis	1.79e-05	2.52e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL1B—osteoarthritis	1.79e-05	2.52e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—ESR1—osteoarthritis	1.79e-05	2.51e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP3—osteoarthritis	1.78e-05	2.5e-05	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—IL6—osteoarthritis	1.78e-05	2.5e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—PTGS2—osteoarthritis	1.78e-05	2.5e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MMP9—osteoarthritis	1.77e-05	2.49e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL1B—osteoarthritis	1.77e-05	2.49e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—FN1—osteoarthritis	1.76e-05	2.48e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—LEP—osteoarthritis	1.76e-05	2.48e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—LEP—osteoarthritis	1.76e-05	2.48e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SMAD3—osteoarthritis	1.76e-05	2.47e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—PTGS2—osteoarthritis	1.75e-05	2.47e-05	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—IL6—osteoarthritis	1.75e-05	2.46e-05	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—IL6—osteoarthritis	1.75e-05	2.46e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—IL6—osteoarthritis	1.75e-05	2.46e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL1B—osteoarthritis	1.74e-05	2.44e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL1B—osteoarthritis	1.74e-05	2.44e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—ESR1—osteoarthritis	1.73e-05	2.44e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—IL6—osteoarthritis	1.73e-05	2.44e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—CXCL8—osteoarthritis	1.73e-05	2.44e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—IL6—osteoarthritis	1.73e-05	2.43e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—PTGS2—osteoarthritis	1.72e-05	2.43e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—FN1—osteoarthritis	1.71e-05	2.41e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—ESR1—osteoarthritis	1.71e-05	2.41e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—IL6—osteoarthritis	1.71e-05	2.4e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—IL6—osteoarthritis	1.71e-05	2.4e-05	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—CXCL8—osteoarthritis	1.7e-05	2.4e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TGFB1—osteoarthritis	1.7e-05	2.4e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SMAD3—osteoarthritis	1.69e-05	2.38e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—FN1—osteoarthritis	1.69e-05	2.38e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TGFB1—osteoarthritis	1.69e-05	2.38e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SMAD3—osteoarthritis	1.68e-05	2.37e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—ESR1—osteoarthritis	1.68e-05	2.37e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—ESR1—osteoarthritis	1.68e-05	2.37e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—LEP—osteoarthritis	1.67e-05	2.35e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—CXCL8—osteoarthritis	1.67e-05	2.35e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—LEP—osteoarthritis	1.67e-05	2.35e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MMP9—osteoarthritis	1.66e-05	2.34e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—FN1—osteoarthritis	1.66e-05	2.34e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—FN1—osteoarthritis	1.66e-05	2.34e-05	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—IL6—osteoarthritis	1.66e-05	2.33e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—IL6—osteoarthritis	1.66e-05	2.33e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—IL6—osteoarthritis	1.65e-05	2.33e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL1B—osteoarthritis	1.65e-05	2.32e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MMP9—osteoarthritis	1.65e-05	2.32e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL1B—osteoarthritis	1.64e-05	2.31e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PTGS2—osteoarthritis	1.63e-05	2.3e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PTGS2—osteoarthritis	1.63e-05	2.3e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IGF1—osteoarthritis	1.63e-05	2.29e-05	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—IL6—osteoarthritis	1.63e-05	2.29e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—IL6—osteoarthritis	1.62e-05	2.29e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGES—osteoarthritis	1.62e-05	2.29e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—CXCL8—osteoarthritis	1.62e-05	2.28e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—IL6—osteoarthritis	1.62e-05	2.28e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SMAD3—osteoarthritis	1.61e-05	2.27e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—CXCL8—osteoarthritis	1.61e-05	2.26e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—CXCL8—osteoarthritis	1.6e-05	2.25e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—ESR1—osteoarthritis	1.6e-05	2.25e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—ESR1—osteoarthritis	1.59e-05	2.24e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—IL6—osteoarthritis	1.58e-05	2.23e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—FN1—osteoarthritis	1.58e-05	2.22e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—FN1—osteoarthritis	1.57e-05	2.21e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—IL6—osteoarthritis	1.57e-05	2.21e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—CXCL8—osteoarthritis	1.55e-05	2.18e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—CXCL8—osteoarthritis	1.55e-05	2.18e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—CXCL8—osteoarthritis	1.55e-05	2.18e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IGF1—osteoarthritis	1.55e-05	2.18e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—IL6—osteoarthritis	1.54e-05	2.17e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—LEP—osteoarthritis	1.54e-05	2.17e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—IL6—osteoarthritis	1.53e-05	2.15e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—IL6—osteoarthritis	1.53e-05	2.15e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—IL6—osteoarthritis	1.53e-05	2.15e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL1B—osteoarthritis	1.52e-05	2.14e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MMP9—osteoarthritis	1.51e-05	2.13e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CXCL8—osteoarthritis	1.51e-05	2.12e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PTGS2—osteoarthritis	1.51e-05	2.12e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—LEP—osteoarthritis	1.5e-05	2.11e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IGF1—osteoarthritis	1.5e-05	2.11e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—IL6—osteoarthritis	1.49e-05	2.1e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IGF1—osteoarthritis	1.48e-05	2.09e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL1B—osteoarthritis	1.48e-05	2.08e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PTGS2—osteoarthritis	1.47e-05	2.07e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—ESR1—osteoarthritis	1.47e-05	2.07e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TGFB1—osteoarthritis	1.46e-05	2.06e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IGF1—osteoarthritis	1.45e-05	2.05e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IGF1—osteoarthritis	1.45e-05	2.05e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MMP9—osteoarthritis	1.45e-05	2.05e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—FN1—osteoarthritis	1.45e-05	2.04e-05	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—IL6—osteoarthritis	1.45e-05	2.04e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—LEP—osteoarthritis	1.45e-05	2.04e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MMP9—osteoarthritis	1.44e-05	2.03e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—IL6—osteoarthritis	1.44e-05	2.03e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—LEP—osteoarthritis	1.44e-05	2.03e-05	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—IL6—osteoarthritis	1.43e-05	2.02e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—ESR1—osteoarthritis	1.43e-05	2.02e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—IL6—osteoarthritis	1.43e-05	2.01e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL1B—osteoarthritis	1.43e-05	2.01e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—IL6—osteoarthritis	1.43e-05	2.01e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL1B—osteoarthritis	1.42e-05	2e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—PTGS2—osteoarthritis	1.42e-05	1.99e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FN1—osteoarthritis	1.42e-05	1.99e-05	CbGpPWpGaD
Sunitinib—BLK—Immune System—IL6—osteoarthritis	1.41e-05	1.99e-05	CbGpPWpGaD
Sunitinib—FGR—Immune System—IL6—osteoarthritis	1.41e-05	1.99e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PTGS2—osteoarthritis	1.41e-05	1.98e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MMP9—osteoarthritis	1.4e-05	1.97e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MMP9—osteoarthritis	1.4e-05	1.97e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—ESR1—osteoarthritis	1.38e-05	1.95e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IGF1—osteoarthritis	1.38e-05	1.94e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IGF1—osteoarthritis	1.38e-05	1.94e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—LEP—osteoarthritis	1.38e-05	1.94e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—ESR1—osteoarthritis	1.37e-05	1.94e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TGFB1—osteoarthritis	1.37e-05	1.93e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MMP9—osteoarthritis	1.36e-05	1.92e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FN1—osteoarthritis	1.36e-05	1.92e-05	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—IL6—osteoarthritis	1.36e-05	1.92e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IL6—osteoarthritis	1.36e-05	1.92e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FN1—osteoarthritis	1.36e-05	1.91e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TGFB1—osteoarthritis	1.36e-05	1.91e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL1B—osteoarthritis	1.36e-05	1.91e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—PTGS2—osteoarthritis	1.35e-05	1.9e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—ESR1—osteoarthritis	1.31e-05	1.85e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CXCL8—osteoarthritis	1.31e-05	1.84e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FN1—osteoarthritis	1.3e-05	1.83e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—TGFB1—osteoarthritis	1.28e-05	1.81e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL6—osteoarthritis	1.28e-05	1.81e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL6—osteoarthritis	1.27e-05	1.79e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IGF1—osteoarthritis	1.27e-05	1.79e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—TGFB1—osteoarthritis	1.27e-05	1.79e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—TGFB1—osteoarthritis	1.25e-05	1.75e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TGFB1—osteoarthritis	1.24e-05	1.75e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CXCL8—osteoarthritis	1.24e-05	1.75e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IGF1—osteoarthritis	1.24e-05	1.75e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CXCL8—osteoarthritis	1.21e-05	1.7e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TGFB1—osteoarthritis	1.2e-05	1.69e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IGF1—osteoarthritis	1.2e-05	1.68e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CXCL8—osteoarthritis	1.19e-05	1.68e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TGFB1—osteoarthritis	1.19e-05	1.68e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IGF1—osteoarthritis	1.19e-05	1.68e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MMP9—osteoarthritis	1.18e-05	1.67e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—TGFB1—osteoarthritis	1.18e-05	1.66e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—TGFB1—osteoarthritis	1.18e-05	1.66e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CXCL8—osteoarthritis	1.17e-05	1.65e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CXCL8—osteoarthritis	1.17e-05	1.65e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TGFB1—osteoarthritis	1.15e-05	1.63e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TGFB1—osteoarthritis	1.15e-05	1.63e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL6—osteoarthritis	1.15e-05	1.62e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GSTO1—osteoarthritis	1.14e-05	1.61e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL6—osteoarthritis	1.14e-05	1.6e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IGF1—osteoarthritis	1.14e-05	1.6e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TGFB1—osteoarthritis	1.12e-05	1.58e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MMP9—osteoarthritis	1.12e-05	1.58e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CXCL8—osteoarthritis	1.11e-05	1.56e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—BGN—osteoarthritis	1.11e-05	1.56e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CXCL8—osteoarthritis	1.11e-05	1.56e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL6—osteoarthritis	1.1e-05	1.55e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MMP9—osteoarthritis	1.09e-05	1.54e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—TGFB1—osteoarthritis	1.09e-05	1.53e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL6—osteoarthritis	1.08e-05	1.52e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MMP9—osteoarthritis	1.08e-05	1.52e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—TGFB1—osteoarthritis	1.06e-05	1.5e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MMP9—osteoarthritis	1.06e-05	1.49e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MMP9—osteoarthritis	1.06e-05	1.49e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL6—osteoarthritis	1.05e-05	1.48e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL6—osteoarthritis	1.04e-05	1.46e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL6—osteoarthritis	1.03e-05	1.45e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—TGFB1—osteoarthritis	1.02e-05	1.44e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL6—osteoarthritis	1.02e-05	1.44e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CXCL8—osteoarthritis	1.02e-05	1.44e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—TGFB1—osteoarthritis	1.02e-05	1.43e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—osteoarthritis	1.02e-05	1.43e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—osteoarthritis	1.02e-05	1.43e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MMP9—osteoarthritis	1e-05	1.41e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP9—osteoarthritis	1e-05	1.41e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CXCL8—osteoarthritis	9.98e-06	1.41e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TGFB1—osteoarthritis	9.77e-06	1.38e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—TGFB1—osteoarthritis	9.73e-06	1.37e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—osteoarthritis	9.72e-06	1.37e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—osteoarthritis	9.68e-06	1.36e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—osteoarthritis	9.65e-06	1.36e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—osteoarthritis	9.62e-06	1.36e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CXCL8—osteoarthritis	9.62e-06	1.35e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CXCL8—osteoarthritis	9.57e-06	1.35e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—osteoarthritis	9.56e-06	1.35e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—osteoarthritis	9.56e-06	1.35e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—osteoarthritis	9.48e-06	1.34e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—osteoarthritis	9.39e-06	1.32e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—osteoarthritis	9.37e-06	1.32e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TGFB1—osteoarthritis	9.26e-06	1.3e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—osteoarthritis	9.25e-06	1.3e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CXCL8—osteoarthritis	9.14e-06	1.29e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—osteoarthritis	9.1e-06	1.28e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—osteoarthritis	9.03e-06	1.27e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—osteoarthritis	9.02e-06	1.27e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TGFB1—osteoarthritis	8.99e-06	1.27e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—osteoarthritis	8.97e-06	1.26e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—osteoarthritis	8.91e-06	1.25e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—osteoarthritis	8.88e-06	1.25e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—osteoarthritis	8.88e-06	1.25e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—osteoarthritis	8.88e-06	1.25e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—osteoarthritis	8.72e-06	1.23e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—osteoarthritis	8.72e-06	1.23e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—osteoarthritis	8.7e-06	1.22e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—osteoarthritis	8.7e-06	1.22e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—osteoarthritis	8.7e-06	1.22e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—osteoarthritis	8.69e-06	1.22e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—osteoarthritis	8.67e-06	1.22e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—osteoarthritis	8.65e-06	1.22e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—osteoarthritis	8.48e-06	1.19e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—osteoarthritis	8.36e-06	1.18e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—osteoarthritis	8.31e-06	1.17e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—osteoarthritis	8.28e-06	1.17e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—osteoarthritis	8.27e-06	1.16e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—osteoarthritis	8.26e-06	1.16e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—osteoarthritis	8.2e-06	1.15e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—osteoarthritis	8e-06	1.13e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—osteoarthritis	7.94e-06	1.12e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—osteoarthritis	7.71e-06	1.09e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—osteoarthritis	7.67e-06	1.08e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—osteoarthritis	7.62e-06	1.07e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—osteoarthritis	7.44e-06	1.05e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—osteoarthritis	7.36e-06	1.04e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—osteoarthritis	7.33e-06	1.03e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—osteoarthritis	7.17e-06	1.01e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—osteoarthritis	7.13e-06	1e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—osteoarthritis	6.98e-06	9.83e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—osteoarthritis	6.85e-06	9.65e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—osteoarthritis	6.81e-06	9.6e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—osteoarthritis	6.78e-06	9.54e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—osteoarthritis	6.69e-06	9.42e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—osteoarthritis	6.57e-06	9.25e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—osteoarthritis	6.57e-06	9.25e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—osteoarthritis	6.24e-06	8.78e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—osteoarthritis	6.22e-06	8.76e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—osteoarthritis	5.74e-06	8.09e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—osteoarthritis	5.6e-06	7.89e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—osteoarthritis	5.4e-06	7.61e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—osteoarthritis	5.37e-06	7.57e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—osteoarthritis	5.17e-06	7.28e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—osteoarthritis	5.14e-06	7.23e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—osteoarthritis	3.19e-06	4.49e-06	CbGpPWpGaD
